Loading...

Apollo Medical Holdings, Inc. Peer Comparison

Metric Value Ranking
Market Cap $1.8 Billion 11/14 UHS
$11.8B
EHC
$9.9B
ENSG
$7.2B
OPCH
$5.4B
ACHC
$3.8B
SGRY
$3.3B
AMED
$3.0B
LFST
$3.0B
SEM
$2.4B
ADUS
$2.1B
AMEH
$1.8B
PNTG
$890.7M
HCSG
$784.9M
INNV
$457.1M
Gross Margin 21% 8/14 PNTG
100%
ACHC
96%
AMED
77%
UHS
72%
EHC
46%
ADUS
33%
SGRY
23%
AMEH
21%
OPCH
20%
INNV
17%
HCSG
15%
ENSG
15%
SEM
11%
LFST
-48%
Profit Margin 6% 7/14 EHC
9%
ACHC
8%
UHS
7%
AMED
7%
ADUS
7%
ENSG
7%
AMEH
6%
OPCH
4%
HCSG
3%
SEM
3%
PNTG
3%
INNV
-2%
LFST
-2%
SGRY
-4%
EBITDA margin 12% 6/14 LFST
177%
SEM
88%
ACHC
20%
EHC
19%
UHS
13%
AMEH
12%
ENSG
11%
ADUS
10%
OPCH
8%
HCSG
5%
AMED
4%
PNTG
3%
INNV
1%
SGRY
-5%
Quarterly Revenue $348.2 Million 10/14 UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
OPCH
$1.3B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
AMED
$587.7M
HCSG
$428.1M
AMEH
$348.2M
LFST
$312.7M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
Quarterly Earnings $22.1 Million 8/14 UHS
$258.7M
EHC
$120.9M
ENSG
$78.4M
ACHC
$68.1M
SEM
$55.6M
OPCH
$53.9M
AMED
$41.5M
AMEH
$22.1M
ADUS
$20.2M
HCSG
$14.0M
PNTG
$6.2M
INNV
-$4.9M
LFST
-$6.0M
SGRY
-$31.7M
Quarterly Free Cash Flow $11.3 Million 10/14 SEM
$289.0M
OPCH
$150.7M
AMED
$104.2M
ENSG
$89.0M
UHS
$81.9M
ADUS
$46.6M
SGRY
$45.0M
PNTG
$18.2M
LFST
$17.7M
AMEH
$11.3M
HCSG
$2.9M
INNV
-$9.7M
ACHC
-$27.1M
EHC
-$0
Trailing 4 Quarters Revenue $1.3 Billion 10/14 UHS
$15.4B
SEM
$7.0B
EHC
$5.4B
OPCH
$4.8B
ENSG
$4.1B
ACHC
$3.1B
SGRY
$3.0B
AMED
$2.3B
HCSG
$1.7B
AMEH
$1.3B
LFST
$1.2B
ADUS
$1.1B
INNV
$786.5M
PNTG
$652.3M
Trailing 4 Quarters Earnings $50.3 Million 9/14 UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
OPCH
$1.3B
ENSG
$1.1B
ACHC
$815.6M
SGRY
$770.4M
AMED
$587.7M
HCSG
$428.1M
AMEH
$348.2M
LFST
$312.7M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
Quarterly Earnings Growth -15% 13/14 HCSG
355%
ACHC
131%
LFST
90%
AMED
60%
UHS
55%
INNV
52%
PNTG
42%
EHC
38%
ADUS
31%
ENSG
23%
SEM
15%
OPCH
-4%
AMEH
-15%
SGRY
-188%
Annual Earnings Growth -16% 12/14 ACHC
34630%
AMED
159%
HCSG
147%
PNTG
66%
INNV
64%
LFST
52%
UHS
51%
EHC
33%
ADUS
23%
SEM
-3%
ENSG
-6%
AMEH
-16%
OPCH
-48%
SGRY
-101%
Quarterly Revenue Growth 10% 9/14 PNTG
29%
LFST
19%
OPCH
17%
ENSG
15%
SGRY
14%
EHC
13%
INNV
12%
UHS
11%
AMEH
10%
ACHC
9%
ADUS
7%
SEM
6%
AMED
6%
HCSG
4%
Annual Revenue Growth 18% 2/14 PNTG
21%
AMEH
18%
LFST
16%
SGRY
12%
OPCH
11%
EHC
10%
ENSG
10%
INNV
10%
UHS
9%
ADUS
8%
ACHC
6%
AMED
5%
SEM
4%
HCSG
2%
Cash On Hand $103.2 Million 8/14 ENSG
$532.1M
OPCH
$483.0M
AMED
$245.5M
ADUS
$222.9M
SGRY
$221.8M
SEM
$191.5M
UHS
$106.1M
AMEH
$103.2M
LFST
$102.6M
EHC
$85.4M
ACHC
$82.1M
HCSG
$53.2M
INNV
$39.0M
PNTG
$4.5M
Short Term Debt $3.2 Million 14/14 SEM
$292.6M
EHC
$164.9M
UHS
$111.2M
SGRY
$97.3M
ACHC
$71.7M
AMED
$63.9M
LFST
$49.0M
HCSG
$25.0M
INNV
$23.1M
PNTG
$19.1M
ADUS
$11.2M
OPCH
$6.5M
ENSG
$4.1M
AMEH
$3.2M
Long Term Debt $0 14/14 UHS
$5.0B
SEM
$4.3B
SGRY
$3.4B
ACHC
$1.8B
OPCH
$1.1B
LFST
$437.7M
AMED
$404.6M
PNTG
$357.8M
EHC
$189.7M
ENSG
$142.6M
INNV
$96.5M
ADUS
$38.6M
HCSG
$9.0M
AMEH
$0
PE 36.37 2/14 PNTG
42.11
AMEH
36.37
ENSG
30.20
ADUS
28.13
OPCH
25.96
AMED
23.80
EHC
21.67
HCSG
15.65
ACHC
13.66
UHS
11.52
SEM
8.65
SGRY
-1.00
INNV
-1.00
LFST
-1.00
PS 1.38 5/14 LFST
2.49
EHC
1.84
ADUS
1.83
ENSG
1.78
AMEH
1.38
PNTG
1.37
AMED
1.31
ACHC
1.23
OPCH
1.14
SGRY
1.10
UHS
0.77
INNV
0.58
HCSG
0.46
SEM
0.34
PB 2.17 7/14 PNTG
4.76
ENSG
4.14
OPCH
3.80
EHC
3.47
AMED
2.53
ADUS
2.19
AMEH
2.17
LFST
2.09
UHS
1.77
SGRY
1.73
HCSG
1.61
INNV
1.57
ACHC
1.22
SEM
1.03
PC 17.73 6/14 PNTG
199.52
EHC
115.65
UHS
111.46
ACHC
46.68
LFST
29.31
AMEH
17.73
SGRY
14.76
HCSG
14.75
ENSG
13.62
AMED
12.37
SEM
12.33
INNV
11.72
OPCH
11.22
ADUS
9.30
Liabilities to Equity 0.00 14/14 SEM
2.98
SGRY
2.97
PNTG
2.71
ENSG
1.65
OPCH
1.40
EHC
1.32
UHS
1.15
INNV
0.91
ACHC
0.90
AMED
0.82
HCSG
0.65
LFST
0.47
ADUS
0.22
AMEH
0.00
ROA 0.06 3/14 UHS
7%
EHC
7%
AMEH
6%
HCSG
6%
AMED
6%
ADUS
6%
OPCH
6%
ACHC
5%
ENSG
5%
SEM
3%
PNTG
3%
SGRY
0%
INNV
-3%
LFST
-5%
ROE -1.00 14/14 EHC
16%
UHS
15%
OPCH
15%
SEM
14%
ENSG
14%
PNTG
12%
AMED
11%
HCSG
10%
ACHC
9%
ADUS
8%
SGRY
0%
INNV
-6%
LFST
-7%
AMEH
-100%
Current Ratio 30.71 1/14 AMEH
30.71
ADUS
5.62
LFST
3.14
HCSG
2.54
AMED
2.28
INNV
2.23
ACHC
2.15
UHS
1.87
EHC
1.77
OPCH
1.71
ENSG
1.61
PNTG
1.41
SEM
1.40
SGRY
1.34
Quick Ratio 3.65 1/14 PNTG
42.11
AMEH
36.37
ENSG
30.20
ADUS
28.13
OPCH
25.96
AMED
23.80
EHC
21.67
HCSG
15.65
ACHC
13.66
UHS
11.52
SEM
8.65
SGRY
-1.00
INNV
-1.00
LFST
-1.00
Long Term Debt to Equity -1.00 14/14 SEM}
2.23
PNTG}
2.11
SGRY}
1.78
OPCH}
0.77
UHS}
0.75
ACHC}
0.60
INNV}
0.37
AMED}
0.35
LFST}
0.30
ENSG}
0.08
EHC}
0.07
ADUS}
0.04
HCSG}
0.02
AMEH}
-1.00
Debt to Equity -1.00 14/14 SEM
2.38
PNTG
2.23
SGRY
1.83
OPCH
0.78
UHS
0.76
ACHC
0.62
INNV
0.42
AMED
0.41
LFST
0.34
EHC
0.13
ENSG
0.08
HCSG
0.07
ADUS
0.05
AMEH
-1.00
Burn Rate -4.86 9/14 ACHC
3.74
LFST
2.87
INNV
2.68
SGRY
1.16
SEM
1.02
PNTG
0.35
EHC
-1.18
UHS
-3.41
AMEH
-4.86
HCSG
-7.17
ENSG
-7.42
ADUS
-14.08
AMED
-26.41
OPCH
-60.20
Cash to Cap 0.06 9/14 ADUS
0.11
OPCH
0.09
INNV
0.09
SEM
0.08
AMED
0.08
HCSG
0.07
SGRY
0.07
ENSG
0.07
AMEH
0.06
LFST
0.03
ACHC
0.02
UHS
0.01
EHC
0.01
PNTG
0.01
CCR 0.51 8/14 SEM
5.20
PNTG
2.93
OPCH
2.80
AMED
2.51
ADUS
2.31
INNV
1.97
ENSG
1.14
AMEH
0.51
UHS
0.32
HCSG
0.21
ACHC
-0.40
SGRY
-1.42
LFST
-2.97
EHC
EV to EBITDA 39.93 7/14 INNV}
392.03
PNTG}
205.05
AMED}
125.37
ADUS}
66.62
OPCH}
59.83
ENSG}
56.16
AMEH}
39.93
EHC}
37.65
HCSG}
33.91
ACHC}
33.88
UHS}
31.83
LFST}
6.12
SEM}
4.34
SGRY}
-181.37
EV to Revenue 1.31 9/14 LFST
2.81
SGRY
2.19
PNTG
1.94
EHC
1.89
ACHC
1.80
ENSG
1.68
ADUS
1.67
AMED
1.40
AMEH
1.31
OPCH
1.27
UHS
1.09
SEM
0.97
INNV
0.67
HCSG
0.45